全文获取类型
收费全文 | 749篇 |
免费 | 108篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 48篇 |
妇产科学 | 9篇 |
基础医学 | 59篇 |
口腔科学 | 8篇 |
临床医学 | 107篇 |
内科学 | 128篇 |
皮肤病学 | 24篇 |
神经病学 | 31篇 |
特种医学 | 130篇 |
外科学 | 153篇 |
综合类 | 10篇 |
现状与发展 | 1篇 |
预防医学 | 51篇 |
眼科学 | 2篇 |
药学 | 40篇 |
中国医学 | 6篇 |
肿瘤学 | 56篇 |
出版年
2023年 | 27篇 |
2022年 | 6篇 |
2021年 | 7篇 |
2020年 | 17篇 |
2019年 | 10篇 |
2018年 | 21篇 |
2017年 | 28篇 |
2016年 | 23篇 |
2015年 | 17篇 |
2014年 | 21篇 |
2013年 | 29篇 |
2012年 | 22篇 |
2011年 | 23篇 |
2010年 | 25篇 |
2009年 | 26篇 |
2008年 | 33篇 |
2007年 | 36篇 |
2006年 | 20篇 |
2005年 | 28篇 |
2004年 | 16篇 |
2003年 | 14篇 |
2002年 | 25篇 |
2001年 | 19篇 |
2000年 | 24篇 |
1999年 | 19篇 |
1998年 | 25篇 |
1997年 | 10篇 |
1996年 | 7篇 |
1995年 | 9篇 |
1994年 | 20篇 |
1993年 | 12篇 |
1992年 | 13篇 |
1991年 | 12篇 |
1990年 | 9篇 |
1989年 | 16篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 8篇 |
1985年 | 9篇 |
1984年 | 13篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 7篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1935年 | 4篇 |
1933年 | 4篇 |
1929年 | 4篇 |
1928年 | 7篇 |
排序方式: 共有867条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
Ross BD; Jacobson S; Villamil F; Korula J; Kreis R; Ernst T; Shonk T; Moats RA 《Radiology》1994,193(2):457
8.
9.
Chou TH Wang S Sakhatskyy PV Mboudjeka I Mboudoudjeck I Lawrence JM Huang S Coley S Yang B Li J Zhu Q Lu S 《Virology》2005,334(1):134-143
Inactivated severe acute respiratory syndrome-associated coronavirus (SARS-CoV) has been tested as a candidate vaccine against the re-emergence of SARS. In order to understand the efficacy and safety of this approach, it is important to know the antibody specificities generated with inactivated SARS-CoV. In the current study, a panel of twelve monoclonal antibodies (mAbs) was established by immunizing Balb/c mice with the inactivated BJ01 strain of SARS-CoV isolated from the lung tissue of a SARS-infected Chinese patient. These mAbs could recognize SARS-CoV-infected cells by immunofluorescence analysis (IFA). Seven of them were mapped to the specific segments of recombinant spike (S) protein: six on S1 subunit (aa 12-798) and one on S2 subunit (aa 797-1192). High neutralizing titers against SARS-CoV were detected with two mAbs (1A5 and 2C5) targeting at a subdomain of S protein (aa 310-535), consistent with the previous report that this segment of S protein contains the major neutralizing domain. Some of these S-specific mAbs were able to recognize cleaved products of S protein in SARS-CoV-infected Vero E6 cells. None of the remaining five mAbs could recognize either of the recombinant S, N, M, or E antigens by ELISA. This study demonstrated that the inactivated SARS-CoV was able to preserve the immunogenicity of S protein including its major neutralizing domain. The relative ease with which these mAbs were generated against SARS-CoV virions further supports that subunit vaccination with S constructs may also be able to protect animals and perhaps humans. It is somewhat unexpected that no N-specific mAbs were identified albeit anti-N IgG was easily identified in SARS-CoV-infected patients. The availability of this panel of mAbs also provided potentially useful agents with applications in therapy, diagnosis, and basic research of SARS-CoV. 相似文献
10.
Louise R Rodino-Klapac Paul ML Janssen Chrystal L Montgomery Brian D Coley Louis G Chicoine K Reed Clark Jerry R Mendell 《Journal of translational medicine》2007,5(1):45-11